Skip to main content
Have a personal or library account? Click to login
Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study Cover

Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study

Open Access
|Oct 2021

References

  1. French KA, Poppas A. Rheumatic Heart Disease in Pregnancy: Global Challenges and Clear Opportunities. Circulation. 2018; 137(8): 8179. DOI: 10.1161/CIRCULATIONAHA.118.033465
  2. Nanna M, Stergiopoulos K. Pregnancy complicated by valvular heart disease: An update. J Am Heart Assoc. 2014; 3(3): e000712. DOI: 10.1161/JAHA.113.000712
  3. Tillquist MN, Maddox TM. Cardiac crossroads: Deciding between mechanical or bioprosthetic heart valve replacement. Patient Preference and Adherence. 2011; 5: 919. DOI: 10.2147/PPA.S16420
  4. Zilla P, Bolman RM, 3rd, Boateng P, Sliwa K. A glimpse of hope: Cardiac surgery in low- and middle-income countries (LMICs). Cardiovasc Diagn Ther. 2020; 10(2): 33649. DOI: 10.21037/cdt.2019.11.03
  5. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39(34): 3165241. DOI: 10.1093/eurheartj/ehy340
  6. Nishimura RA, Warnes CA. Anticoagulation during pregnancy in women with prosthetic valves: Evidence, guidelines and unanswered questions. Heart. 2015; 101(6): 4305. DOI: 10.1136/heartjnl-2014-306500
  7. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology; 2014.
  8. D’Souza R, Silversides CK, McLintock C. Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves. Semin Thromb Hemost. 2016; 42(7): 798804. DOI: 10.1055/s-0036-1593418
  9. D’Souza R, Ostro J, Shah PS, et al. Anticoagulation for pregnant women with mechanical heart valves: A systematic review and meta-analysis. Eur Heart J. 2017; 38(19): 150916. DOI: 10.1093/eurheartj/ehx032
  10. Malhamé I, Othman M, Casais P, et al. Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Survey – Communication from the ISTH Women’s Subcommittee. J Thromb Haemost. 2020; accepted.
  11. Baghel J, Keepanasseril A, Pillai AA, Mondal N, Jeganathan Y, Kundra P. Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease. Heart. 2020; 106(18): 14006. DOI: 10.1136/heartjnl-2020-316648
  12. Walfisch A, Koren G. The ‘warfarin window’ in pregnancy: The importance of half-life. J Obstet Gynaecol Can. 2010; 32(10): 9889. DOI: 10.1016/S1701-2163(16)34689-8
  13. Soma-Pillay P, Nene Z, Mathivha T, Macdonald AP. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstetric Medicine. 2011; 4: 247. DOI: 10.1258/om.2010.100067
  14. Tuncalp O, Souza JP, Gulmezoglu M, World Health Organization. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet. 2013; 123(3): 2546. DOI: 10.1016/j.ijgo.2013.06.024
  15. Joseph KS. The fetuses-at-risk approach: Clarification of semantic and conceptual misapprehension. BMC Pregnancy Childbirth. 2008; 8: 11. DOI: 10.1186/1471-2393-8-11
  16. Bhagra CJ, D’Souza R, Silversides CK. Valvular heart disease and pregnancy part II: Management of prosthetic valves. Heart. 2017; 103(3): 24452. DOI: 10.1136/heartjnl-2015-308199
  17. van Hagen IM, Roos-Hesselink JW, Ruys TP, et al. Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015; 132(2): 13242. DOI: 10.1161/CIRCULATIONAHA.115.015242
  18. Vause S, Clarke B, Tower CL, Hay C, Knight M. Pregnancy outcomes in women with mechanical prosthetic heart valves: A prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system. BJOG. 2017; 124(9): 14119. DOI: 10.1111/1471-0528.14478
  19. Brancazio LR, Roperti KA, Stierer R, Laifer SA. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol. 1995; 173(4): 12405. DOI: 10.1016/0002-9378(95)91362-9
  20. Ensom MH, Stephenson MD. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig. 2004; 11(6): 37783. DOI: 10.1016/j.jsgi.2004.02.007
  21. Xu Z, Fan J, Luo X, et al. Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis. Can J Cardiol. 2016; 32(10): 1248 e1–e9. DOI: 10.1016/j.cjca.2015.11.005
  22. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. Journal of the American College of Cardiology. 1999; 33(6): 163741. DOI: 10.1016/S0735-1097(99)00044-3
  23. Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: A meta-analysisdagger. Interactive cardiovascular and thoracic surgery. 2014; 18(6): 797806. DOI: 10.1093/icvts/ivu009
  24. Dhillon SK, Edwards J, Wilkie J, Bungard TJ. High-Versus Low-Dose Warfarin-Related Teratogenicity: A Case Report and Systematic Review. J Obstet Gynaecol Can. 2018; 40(10): 134857. DOI: 10.1016/j.jogc.2017.11.020
  25. McLintock C. Thromboembolism in pregnancy: Challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. Best practice & research Clinical obstetrics & gynaecology. 2014; 28(4): 51936. DOI: 10.1016/j.bpobgyn.2014.03.001
  26. Bujold E, Roberge S, Nicolaides KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn. 2014; 34(7): 6428. DOI: 10.1002/pd.4403
  27. Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 216(2): 11020 e6. DOI: 10.1016/j.ajog.2016.09.076
DOI: https://doi.org/10.5334/gh.1011 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 20, 2021
Accepted on: Sep 22, 2021
Published on: Oct 13, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Anish Keepanasseril, Ajith Ananthakrishna Pillai, Jyoti Baghel, Swaraj Nandini Pande, Nivedita Mondal, Hemachandren Munuswamy, Pankaj Kundra, Rohan D’Souza, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.